Last updated on November 2017

ABSORB IV Randomized Controlled Trial


Brief description of study

ABSORB IV Randomized Controlled Trial

Detailed Study Description

Clinical Evaluation of the Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects with de novo Native Coronary Artery Lesions

Clinical Study Identifier: TX3676

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Sara Renfrow

Baptist Health Clinical Research Center & Lexington Cardiac Research Foundation
Lexington, KY USA
  Connect »